Almanac 2012: Interventional cardiology

Gray, 2010, Early management of unstable angina and non-ST-segment elevation myocardial infarction: summary of NICE guidance, Heart, 96, 1662, 10.1136/hrt.2010.204511 Boden, 2007, Optimal medical therapy with or without PCI for stable coronary disease, N Engl J Med, 356, 1503, 10.1056/NEJMoa070829 Weintraub, 2008, Effect of PCI on quality of life in patients with stable coronary disease, N Engl J Med, 359, 677, 10.1056/NEJMoa072771 Stergiopoulos, 2012, Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials, Arch Intern Med, 172, 312, 10.1001/archinternmed.2011.1484 Henderson, 2012, Management of stable angina: summary of NICE guidance, Heart, 98, 500, 10.1136/heartjnl-2011-301436 Borden, 2011, Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention, JAMA, 305, 1882, 10.1001/jama.2011.601 Aversano, 2012, Outcomes of PCI at hospitals with or without on-site cardiac surgery, N Engl J Med, 366, 1792, 10.1056/NEJMoa1114540 Singh, 2011, Percutaneous coronary intervention at centers with and without on-site surgery: a meta-analysis, JAMA, 306, 2487, 10.1001/jama.2011.1790 Epstein, 2011, Coronary revascularization trends in the United States, 2001-2008, JAMA, 305, 1769, 10.1001/jama.2011.551 Taggart, 2011, The 2010 ESC/EACTS guidelines on myocardial revascularisation, Heart, 97, 445, 10.1136/hrt.2010.216135 Chan, 2011, Appropriateness of percutaneous coronary intervention, JAMA, 306, 53 Cohen, 2011, Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery, N Engl J Med, 364, 1016, 10.1056/NEJMoa1001508 Weintraub, 2012, Comparative effectiveness of revascularization strategies, N Engl J Med, 366, 1467, 10.1056/NEJMoa1110717 Rao, 2011, Prevalence and outcomes of same-day discharge after elective percutaneous coronary intervention among older patients, JAMA, 306, 1461, 10.1001/jama.2011.1409 Khawaja, 2012, Factors associated with 30-day readmission rates after percutaneous coronary intervention, Arch Intern Med, 172, 112, 10.1001/archinternmed.2011.569 Brennan, 2012, Characteristics and long-term outcomes of percutaneous revascularization of unprotected left main coronary artery stenosis in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008, J Am Coll Cardiol, 59, 648, 10.1016/j.jacc.2011.10.883 Park, 2011, Randomized trial of stents versus bypass surgery for left main coronary artery disease, N Engl J Med, 364, 1718, 10.1056/NEJMoa1100452 de la Torre Hernandez, 2011, Prospective application of pre-defined intravascular ultrasound criteria for assessment of intermediate left main coronary artery lesions results from the multicenter LITRO study, J Am Coll Cardiol, 58, 351, 10.1016/j.jacc.2011.02.064 Garg, 2010, Drug-eluting stents: a reappraisal, Heart, 96, 489, 10.1136/hrt.2009.189522 de Waha, 2011, Long-term outcome after sirolimus-eluting stents versus bare metal stents in patients with diabetes mellitus: a patient-level meta-analysis of randomized trials, Clin Res Cardiol, 100, 561, 10.1007/s00392-010-0278-8 Baber, 2011, Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials, J Am Coll Cardiol, 58, 1569, 10.1016/j.jacc.2011.06.049 Palmerini, 2012, Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis, Lancet, 379, 1393, 10.1016/S0140-6736(12)60324-9 Meier, 2010, Drug-eluting versus bare-metal stent for treatment of saphenous vein grafts: a meta-analysis, PLoS One, 5, e11040, 10.1371/journal.pone.0011040 Kalesan, 2012, Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction, Eur Heart J, 33, 977, 10.1093/eurheartj/ehs036 Serruys, 2011, Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes, J Am Coll Cardiol, 58, 1578, 10.1016/j.jacc.2011.05.050 Johnman, 2012, Clinical outcomes following radial versus femoral artery access in primary or rescue percutaneous coronary intervention in Scotland: retrospective cohort study of 4534 patients, Heart, 98, 552, 10.1136/heartjnl-2011-301032 Patterson, 2011, If the radial artery is the new standard of care in primary percutaneous coronary intervention, why is most intervention done by the femoral approach?, Heart, 97, 521, 10.1136/hrt.2010.207043 Cayla, 2011, Trans-radial approach for catheterisation in non-ST segment elevation acute coronary syndrome: an analysis of major bleeding complications in the ABOARD Study, Heart, 97, 887, 10.1136/hrt.2010.220137 Mamas, 2012, Influence of access site selection on PCI-related adverse events in patients with STEMI: meta-analysis of randomised controlled trials, Heart, 98, 303, 10.1136/heartjnl-2011-300558 Vink, 2011, Routine use of the transradial approach in primary percutaneous coronary intervention: procedural aspects and outcomes in 2209 patients treated in a single high-volume centre, Heart, 97, 1938, 10.1136/heartjnl-2011-300524 Amoroso, 2010, Transradial access for primary percutaneous coronary intervention: the next standard of care?, Heart, 96, 1341, 10.1136/hrt.2010.196824 Vuurmans, 2010, Chronic kidney injury in patients after cardiac catheterisation or percutaneous coronary intervention: a comparison of radial and femoral approaches (from the British Columbia Cardiac and Renal Registries), Heart, 96, 1538, 10.1136/hrt.2009.192294 Jolly, 2011, Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial, Lancet, 377, 1409, 10.1016/S0140-6736(11)60404-2 Siller-Matula, 2010, Impact of clopidogrel loading dose on clinical outcome in patients undergoing percutaneous coronary intervention:a systematic review and meta-analysis, Heart, 97, 98, 10.1136/hrt.2010.195438 Patti, 2011, J Am Coll Cardiol, 58, 1592, 10.1016/j.jacc.2011.06.044 Breet, 2011, High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention, Heart, 97, 983, 10.1136/hrt.2010.220491 Bouman, 2011, Variability in on-treatment platelet reactivity explained by CYP2C19*2 genotype is modest in clopidogrel pretreated patients undergoing coronary stenting, Heart, 97, 1239, 10.1136/hrt.2010.220509 Park, 2011, Cilostazol attenuates on-treatment platelet reactivity in patients with CYP2C19 loss of function alleles receiving dual antiplatelet therapy: a genetic substudy of the CILON-T randomised controlled trial, Heart, 97, 641, 10.1136/hrt.2010.216499 Price, 2011, Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial, JAMA, 305, 1097, 10.1001/jama.2011.290 Sambu, 2011, Effect of clopidogrel withdrawal on platelet reactivity and vascular inflammatory biomarkers 1 year after drug-eluting stent implantation: results of the prospective, single-centre CESSATION study, Heart, 97, 1661, 10.1136/heartjnl-2011-300192 Warner, 2010, Dual antiplatelet therapy in cardiovascular disease: does aspirin increase clinical risk in the presence of potent P2Y12 receptor antagonists?, Heart, 96, 1693, 10.1136/hrt.2010.205724 Smit, 2010, Prehospital triple antiplatelet therapy in patients with acute ST elevation myocardial infarction leads to better platelet aggregation inhibition and clinical outcome than dual antiplatelet therapy, Heart, 96, 1815, 10.1136/hrt.2010.201889 Hill, 2010, Prasugrel for the treatment of acute coronary syndromes with percutaneous coronary intervention: NICE technology appraisal guidance, Heart, 96, 1407, 10.1136/hrt.2010.202853 Eshaghian, 2010, Advances in antiplatelet treatment for acute coronary syndromes, Heart, 96, 656, 10.1136/hrt.2009.185983 Wiviott, 2007, Prasugrel versus clopidogrel in patients with acute coronary syndromes, N Engl J Med, 357, 2001, 10.1056/NEJMoa0706482 Wallentin, 2009, Ticagrelor versus clopidogrel in patients with acute coronary syndromes, N Engl J Med, 361, 1045, 10.1056/NEJMoa0904327 Mahoney, 2010, Circulation, 121, 71, 10.1161/CIRCULATIONAHA.109.900704 Nikolic E, Janzon M, Hauch O, et al. Cost-effectiveness of treating acute coronary syndrome patients with ticagrelor for 12 months: results from the PLATO study. Eur Heart J. Published Online First: 19 June 2012. Hochtl, 2010, New anticoagulant agents in acute coronary syndromes, Heart, 97, 244, 10.1136/hrt.2009.184333 Stone, 2011, Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial, Lancet, 377, 2193, 10.1016/S0140-6736(11)60764-2 Schwenkglenks, 2012, Cost-effectiveness of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitor in the treatment of acute ST- segment elevation myocardial infarction, Heart, 98, 544, 10.1136/heartjnl-2011-301323 Koutouzis, 2011, Heart, 97, 1484, 10.1136/hrt.2011.224709 Langrish, 2011, Optimal antithrombotic treatment during primary percutaneous coronary intervention?, Heart, 97, 1459, 10.1136/heartjnl-2011-300367 Silvain, 2012, Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis, BMJ, 344, e553, 10.1136/bmj.e553 Parise, 2011, Meta-analysis of randomized studies comparing intravascular ultrasound versus angiographic guidance of percutaneous coronary intervention in pre-drug-eluting stent era, Am J Cardiol, 107, 374, 10.1016/j.amjcard.2010.09.030 Gauss, 2011, Assessment of coronary artery remodelling by dual-source CT: a head-to-head comparison with intravascular ultrasound, Heart, 97, 991, 10.1136/hrt.2011.223024 Schepis, 2010, Quantification of non-calcified coronary atherosclerotic plaques with dual-source computed tomography: comparison with intravascular ultrasound, Heart, 96, 610, 10.1136/hrt.2009.184226 Tahara, 2010, Angiographic, IVUS and OCT evaluation of the long-term impact of coronary disease severity at the site of overlapping drug-eluting and bare metal stents: a substudy of the ODESSA trial, Heart, 96, 1574, 10.1136/hrt.2009.188037 Inoue, 2010, Optical coherence evaluation of everolimus-eluting stents 8 months after implantation, Heart, 97, 1379, 10.1136/hrt.2010.204339 Stone, 2011, A prospective natural-history study of coronary atherosclerosis, N Engl J Med, 364, 226, 10.1056/NEJMoa1002358 Li, 2010, Relationship between plasma inflammatory markers and plaque fibrous cap thickness determined by intravascular optical coherence tomography, Heart, 96, 196, 10.1136/hrt.2009.175455 Her, 2011, Long-term clinical outcomes of overlapping heterogeneous drug-eluting stents compared with homogeneous drug-eluting stents, Heart, 97, 1501, 10.1136/hrt.2011.226308 Behan, 2011, Simple or complex stenting for bifurcation coronary lesions: a patient-level pooled-analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study, Circ Cardiovasc Interv, 4, 57, 10.1161/CIRCINTERVENTIONS.110.958512 Gwon, 2011, Final kissing ballooning and long-term clinical 91. outcomes in coronary bifurcation lesions treated with 1-stent technique: results from the COBIS registry, Heart, 98, 225, 10.1136/heartjnl-2011-300322 Mills, 2011, Implementation of a sensitive troponin I 92. assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome, JAMA, 305, 1210, 10.1001/jama.2011.338 Jaffe, 2010, Clin Chem, 56, 941, 10.1373/clinchem.2010.143958 Mills, 2012, Implications of lowering threshold of plasma troponin concentration in diagnosis of myocardial infarction: cohort study, BMJ, 344, e1533, 10.1136/bmj.e1533 Baker, 2011, Troponins: redefining their limits, Heart 96, 97, 447, 10.1136/hrt.2010.205617 Korosoglou, 2010, Determinants of troponin release in patients with stable coronary artery disease: insights from CT angiography characteristics of atherosclerotic plaque, Heart, 97, 823, 10.1136/hrt.2010.193201 Goodacre, 2010, The Randomised Assessment of Treatment using Panel Assay of Cardiac Markers (RATPAC) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department, Heart, 97, 99 Fox, 2010, The Global registry of acute coronary events, 1999 to 2009-GRACE, Heart, 96, 1095, 10.1136/hrt.2009.190827 Jolly, 2010, Quantitative troponin and death, cardiogenic shock, cardiac arrest and new heart failure in patients with non-ST- segment elevation acute coronary syndromes (NSTE ACS): insights from the Global Registry of Acute Coronary Events, Heart, 97, 197, 10.1136/hrt.2010.195511 Politi, 2010, A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up, Heart, 96, 662, 10.1136/hrt.2009.177162 Vlaar, 2011, Culprit vessel only versus multivessel 102. and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis, J Am Coll Cardiol, 58, 692, 10.1016/j.jacc.2011.03.046 Kornowski, 2011, Prognostic impact of staged versus “one-time” multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial, J Am Coll Cardiol, 58, 704, 10.1016/j.jacc.2011.02.071 Suarez-Barrientos, 2011, Circadian variations of infarct size in acute myocardial infarction, Heart, 97, 970, 10.1136/hrt.2010.212621 Eitel, 2011, Long-term prognostic value of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction, Heart, 97, 2038, 10.1136/heartjnl-2011-300098 Mather, 2010, Reperfusion haemorrhage as determined 106. by cardiovascular MRI is a predictor of adverse left ventricular remodelling and markers of late arrhythmic risk, Heart, 97, 453, 10.1136/hrt.2010.202028 O’Regan, 2010, Assessment of severe reperfusion injury with T2* cardiac MRI in patients with acute myocardial infarction, Heart, 96, 1885, 10.1136/hrt.2010.200634 Kharbanda, 2010, Cardiac conditioning: a review of evolving strategies to reduce ischaemia-reperfusion injury, Heart, 96, 1179, 10.1136/hrt.2009.179101 Ludman, 2011, Effect of erythropoietin as an adjunct to primary percutaneous coronary intervention: a randomised controlled clinical trial, Heart, 97, 1560, 10.1136/hrt.2011.223867 Pedersen, 2011, Bradykinin does not mediate remote ischaemic preconditioning or ischaemia-reperfusion injury in vivo in man, Heart, 97, 1857, 10.1136/heartjnl-2011-300323 Ikonomidis, 2010, Staccato reperfusion improves myocardial microcirculatory function and long-term left ventricular remodelling: a randomised contrast echocardiography study, Heart, 96, 1898, 10.1136/hrt.2010.201681 Sorensson, 2010, Effect of postconditioning on infarct size in 112. patients with ST elevation myocardial infarction, Heart, 96, 1710, 10.1136/hrt.2010.199430 Patel, 2011, Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the 113. CRISP AMI randomized trial, JAMA, 306, 1329, 10.1001/jama.2011.1280 Reed, 2009, The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials, JACC Cardiovasc Interv, 2, 645, 10.1016/j.jcin.2009.05.002 Wi, 2011, Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with 115. acute myocardial infarction undergoing percutaneous coronary intervention, Heart, 97, 1753, 10.1136/hrt.2010.218677 Gallagher, 2011, Contrast-induced nephropathy in primary percutaneous coronary intervention, Heart, 97, 1723, 10.1136/heartjnl-2011-300517 Meier, 2010, Is simpler also better? Brief sodium bicarbonate infusion to prevent contrast-induced nephropathy, Am J Cardiol, 105, 1042, 10.1016/j.amjcard.2009.11.011 Hekimian, 2010, Preoperative use and safety of coronary angiography for acute aortic valve infective endocarditis, Heart, 96, 696, 10.1136/hrt.2009.183772 O’Leary, 2011, Effect of rimonabant on carotid intima-media thickness (CIMT) progression in patients with abdominal obesity and metabolic syndrome: the AUDITOR Trial, Heart, 97, 1143, 10.1136/hrt.2011.223446 Roffi, 2010, Peripheral arterial disease. Current evidence for carotid endarterectomy and carotid artery stenting, Heart, 96, 636, 10.1136/hrt.2009.169151 Brott, 2010, Stenting versus endarterectomy for treatment of carotid-artery stenosis, N Engl J Med, 363, 11, 10.1056/NEJMoa0912321 Meier, 2010, Short term and intermediate term comparison of endarterectomy versus stenting for carotid artery stenosis: systematic review and meta-analysis of randomised controlled clinical trials, BMJ, 340, c467, 10.1136/bmj.c467 Neequaye, 2011, Carotid artery stenting: the 2011 NICE guidelines, Heart, 98, 274, 10.1136/heartjnl-2011-301218 Venkatachalam, 2010, Contemporary management of concomitant carotid and coronary artery disease, Heart, 97, 175, 10.1136/hrt.2010.203612 Xie, 2011, Combination of carotid intima-media thickness and plaque for better predicting risk of ischaemic cardiovascular events, Heart, 97, 1326, 10.1136/hrt.2011.223032 Kodali, 2012, Two-year outcomes after transcatheter or surgical aortic-valve replacement, N Engl J Med, 366, 1686, 10.1056/NEJMoa1200384 Abdel-Wahab, 2010, Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry, Heart, 97, 899, 10.1136/hrt.2010.217158 Rodes-Cabau, 2011, Incidence, predictive factors, and prognostic value of myocardial injury following uncomplicated transcatheter aortic valve implantation, J Am Coll Cardiol, 57, 1988, 10.1016/j.jacc.2010.11.060 Reynolds, 2011, Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis, Circulation, 124, 1964, 10.1161/CIRCULATIONAHA.111.040022 Gotzmann, 2010, Short-term effects of transcatheter aortic valve implantation on neurohormonal activation, quality of life and 6-minute walk test in severe and symptomatic aortic stenosis, Heart, 96, 1102, 10.1136/hrt.2009.180661 Watt, 2011, Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement, Heart, 98, 370, 10.1136/heartjnl-2011-300444 Reynolds, 2012, Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B), Circulation, 125, 1102, 10.1161/CIRCULATIONAHA.111.054072 Piazza, 2010, Adherence to patient selection criteria in patients undergoing transcatheter aortic valve implantation with the 18F CoreValve ReValving System, Heart, 96, 19, 10.1136/hrt.2009.172809 Tamburino, 2010, TAVI as a threat to surgical practice: “much ado about nothing” or “the quiet before the storm”?, Heart, 96, 1609, 10.1136/hrt.2010.208983 Grant, 2010, What is the impact of providing a transcatheter aortic valve implantation service on conventional aortic valve surgical activity: patient risk factors and outcomes in the first 2 years, Heart, 96, 1633, 10.1136/hrt.2010.203661 Farouque, 2010, Percutaneous mitral valve leaflet repair for mitral regurgitation: NICE guidance, Heart, 96, 385, 10.1136/hrt.2009.183269 Feldman, 2009, Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort, J Am Coll Cardiol, 54, 686, 10.1016/j.jacc.2009.03.077 Glower, 2012, EVEREST II randomized clinical trial: predictors of mitral valve replacement in de novo surgery or after the MitraClip procedure, J Thorac Cardiovasc Surg, 143, S60, 10.1016/j.jtcvs.2012.01.047 Gaemperli, 2012, Acute haemodynamic changes after percutaneous mitral valve repair: relation to mid-term outcomes, Heart, 98, 126, 10.1136/heartjnl-2011-300705 Nagueh, 2011, Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry, J Am Coll Cardiol, 58, 2322, 10.1016/j.jacc.2011.06.073 Ball, 2011, Long-term survival in patients with resting obstructive hypertrophic cardiomyopathy comparison of conservative versus invasive treatment, J Am Coll Cardiol, 58, 2313, 10.1016/j.jacc.2011.08.040 Galve, 2010, Late benefits of dual-chamber pacing in obstructive hypertrophic cardiomyopathy: a 10-year follow-up study, Heart, 96, 352, 10.1136/hrt.2008.158915 Jensen, 2011, Long-term outcome of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: a Scandinavian multicenter study, Circ Cardiovasc Interv, 4, 256, 10.1161/CIRCINTERVENTIONS.110.959718